Synthesis and antinociceptive activity of (5-chloro-2(3H)-benzothiazolon-3- yl)propanamide derivatives

Archiv der Pharmazie

Volumn 337, Issue 9, 2004, Pages 475-481

  Ökol, Tijen ^a   Yildirim, Engin ^b   Erol, Kevser ^b   Ito, Shigero ^c   Şahin, M Fethi ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

(5 Chloro 2(3H) benzothiazolon 3 yl) propanamide derivatives; 5 Chloro 2(3H) benzothiazolone; Antinociceptive activity

Indexed keywords

1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (2 FLUOROPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (2 METHOXYPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (2 PYRIDYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (3 CHLOROPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (4 CHLOROPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 (4 FLUOROPHENYL)PIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 BENZYLPIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 PHENYLPIPERAZINE; 1 [3 [5 CHLORO 2(3H) BENZOTHIAZOLON 3 YL)PROPANOYL] 4 PIPERONYLPIPERAZINE; BENZOTHIAZOLE DERIVATIVE; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; EXPERIMENTAL TEST; HOT PLATE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TAIL CLIP TEST; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; MICE; MOLECULAR STRUCTURE; PAIN; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 4644361589     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300863     Document Type: Article

References (32)

1. S. Yous, J. H. Poupaert, P, Chavatte, J. G. B. Espiard, D. H. Caignard, D. Lesieur, Drug Design and Discovery 2001, 17, 331-336.
2. T. Takashima, Y. Kadoh, S. Kumada, Arzneim.-Forsch. Drug Res. 1972, 22(4), 711-715.
3. Fujisawa Pharmaceutical Co. Ltd, Jpn. Kopkai Tokkyo Koho, JP 5 953 475, 1984. [Chem. Abst. 1984, 101, 90983d.]
4. T. Onkol, Y. Dündar, B. Sirmagül, K. Erol, M. F. Sahin, J. Fac. Pharm. Gazi 2002, 19(1), 15-24.
5. D. S. Dogruer, S. Ünlü, E. Yeşilada, M. F. Şahin, Farmaco 1997, 52(12), 745-750.
6. H. Nakamura, A. Shimoda, K. Ishii, T. Kadokawa, Arch. Int. Pharmacodyn. 1986, 282, 16-25.
7. G. C. Wermuth, Aggressologie 1965, 6, 383-398.
8. M. Takaya, M. Sato, H. Terashima, H. Tanizawa, Y. Maki, J. Med. Chem. 1979, 22, 53-58.
9. M. Sato, Y. Ishizuka, A. Yamaguchi, Arzneim. Forsch. 1981, 31, 1738-1745.
10. M. Sato, A. Yamaguchi, Arzneim. Forsch. 1982, 32, 379-382.
11. C. Rubat, P. Coudert, E. Albuisson, J. Bastide, J. Couquelet, P. Tranche, J. Pharm. Sci. 1992, 81, 1084-1087.
12. V. Dal Piaz, M. P. Giovannoni, G. Ciciani, D. Barlocco, G. Giardina, G. Pétrone, G. D. Clarke, Eur. J. Med. Chem. 1996, 31, 65-70.
13. M. C. Viaud, P. Jamoneau, C. Flouzat, J. G. Bizot-Espiard, B. Pfeiffer, P. Renard, D. H. Caignard, G. Adam, G. Guillaumet, J. Med. Chem. 1995, 38, 1278-1286.
14. V. D. Piaz, C. Vergelli, M. P. Giovannoni, M. A. Scheideler, G. Petrone, P. Zaratin, Farmaco 2003, 58, 1063-1071.
15. T. Onkol, D. S. Dogruer, S. Ito, M. F. Şahin, Arch. Pharm. Pharm. Med. Chem. 2000, 333(10), 337-340.
16. T. Onkol, S. Ito, E. Yildirim, K. Erol, M. F. Şahin, Arch. Pharm. Pharm. Med. Chem. 2001, 334(1), 17-20.
17. B. Çakir, A. Uluçay, S. D. Dogruer, A. Işimer, M. F. Şahin, Farmaco 1999, 54, 846-851.
18. E. Hoggarth, J. Chem. Soc. 1949, 3311-3315.
19. J. J. D'Amico, F. G. Bollinger, J. Heterocyclic Chem. 1988, 25, 1183-1190.
20. J. J. D'Amico, F. G. Bollinger, J. Heterocyclic Chem. 1988, 25, 1487-1496.
21. V. Kalcheva, D. Simov, God. Sofii Univ. Khim. Fak. 1972, 64, 33. [Chem. Abst., 1973, 78, 59504z.]
22. V. Kalcheva, D. Simov, God. Sofii Univ. Khim. Fak. 1972, 64, 33. [Chem. Abst., 1973, 78, 59504z.]
23. K. Fujii, J. Pharm. Soc. Japan 1957, 77, 1065-1070.
24. B. Bannwart, F. Demotes-Mainard, T. Schaeverbeke, L. Labat, J. Dehais, Fundam. Clin. Pharmacol. 1995, 9, 1-7.
25. H. Akman, F. Aksu, I. Gülekin, K. Erol, H. Özbek, U. Oral, F. Doran, Pharmacology 1996, 53, 71-78.
26. P. Aguirre-Banuelos, V. Granados-Soto, Proc. West. Pharmacol. 2000, 43, 11-14.
27. R. Koster, M. Anderson, E. J. Beer, Fed. Proc. 1959, 18, 412.
28. C. Bianchi, J. Franceschini, Br. J. Pharmacol. 1954, 9, 280-284.
29. E. Z. Daajani, K. R. Larsen, J. Taylor, N. E. Dajani, T. G. Schwan, S. D. Neelemen, M. S. Taylor, T. Dayton, G. N. Mir, J. Pharmacol. Exp. Ther. 1999, 291(1), 31-38.
30. F. E. D'Amour, D. L. Smith, J. Pharmacol. Exp. Ther. 1941, 72, 74-79.
31. N. B. Eddy, D. Leimbach, J. Pharmacol. Exp. Ther. 1953, 107, 385-393.
32. F. Noble, C. Smadja, B. P. Ragues, J. Pharmacol. Exp. Ther. 1994, 271, 1127-1134.